Ulinastatin reduces cancer recurrence after resection of hepatic metastases from colon cancer by inhibiting MMP-9 activation via the antifibrinolytic pathway.
about
Complement 5a Enhances Hepatic Metastases of Colon Cancer via Monocyte Chemoattractant Protein-1-mediated Inflammatory Cell Infiltration.Synergism from the combination of ulinastatin and curcumin offers greater inhibition against colorectal cancer liver metastases via modulating matrix metalloproteinase-9 and E-cadherin expression.Associations of MMP-2 and MMP-9 gene polymorphism with ulinastatin efficacy in patients with severe acute pancreatitis.The Anticancer Role of Capsaicin in Experimentallyinduced Lung Carcinogenesis.
P2860
Ulinastatin reduces cancer recurrence after resection of hepatic metastases from colon cancer by inhibiting MMP-9 activation via the antifibrinolytic pathway.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Ulinastatin reduces cancer rec ...... the antifibrinolytic pathway.
@en
type
label
Ulinastatin reduces cancer rec ...... the antifibrinolytic pathway.
@en
prefLabel
Ulinastatin reduces cancer rec ...... the antifibrinolytic pathway.
@en
P2093
P2860
P356
P1476
Ulinastatin reduces cancer rec ...... the antifibrinolytic pathway.
@en
P2093
Huan-Qing Xiao
Jiang-Lin Li
Kun-Ping Li
Qi-Cai Liu
Wen-Song Cai
P2860
P304
P356
10.1155/2013/437950
P407
P577
2013-04-23T00:00:00Z